Last update 21 Nov 2024

ZTL-106

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Mechanism-
Therapeutic Areas
Other Diseases
Active Indication
Musculoskeletal Injury
Inactive Indication-
Originator Organization
Zelira Therapeutics Ltd.Zelira Therapeutics Ltd.
Active Organization
Zelira Therapeutics Ltd.Zelira Therapeutics Ltd.
Inactive Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with ZTL-106
ACTRN12622000120774 / Not yet recruitingPhase 2
A phase 2a, randomised, double-blind, placebo controlled study to evaluate the efficacy of ZTL-106 in treating patients with chronic pain as a result of a musculoskeletal injury
100 Clinical Results associated with ZTL-106
Login to view more data
100 Translational Medicine associated with ZTL-106
Login to view more data
100 Patents (Medical) associated with ZTL-106
Login to view more data
100 Deals associated with ZTL-106
Login to view more data

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free